Cailin Conner

DocwireNews

Gout has an incidence of 2.74 per 1,000 person-years and is linked to increased risks of mortality and comorbidities. It is an inflammatory disease caused by the accumulation of monosodium urate in and around the joints due to elevated levels of serum urate (hyperuricaemia) in the blood. Of the comorbidities associated with gout, cardiovascular disease and hypertension are two of the most commonly reported. There have been several studies that have investigated the relationship between gout and hypertension, with studies suggesting hyperuricemia is associated with arterial stiffness, insulin level, alterations in the renin-angiotensin system, and endothelial dysfunction. However, many of these studies were observational, and causality between gout and hypertension could not be established.&ldquo;Our work aims to assess the causal relationship between gout and hypertension,&rdquo; authors wrote regarding their study published in <a href="https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-022-02933-4" target="_blank" rel="noopener">Arthritis Research &amp; Therapy</a>. Using prospectively collected genetic information, 88,347 participants and 686,439 single-nucleotide polymorphisms (SNPs) were included in the analysis. The authors of the study used a novel model of Mendelian randomization (MR), a method of using measured variation in genes of known function to examine the causal effect of a modifiable exposure on disease, to examine the causality between the liability of gout on hypertension and vice versa, using five SNPs associated with gout and 10 SNPs associated with hypertension.MR analysis was conducted using two methods: inverse-variance weighted (IVW) and polygenic risk score (PRS). IVW method, a more suitable than the random-effects method, aggregates two or more random variables to minimize the variance of the weighted average. PRS, on the other hand, is used to represent the total number of genetic variants that an individual has in order to assess their heritable risk of developing a particular disease.Of the study participants, 3.86% had gout and 13.52% had hypertension. The mean age of participants was 51.1 years. Patients with gout and/or hypertension were more likely to be male, be older, have increased BMI and urate levels, and have worse kidney function.After MR analysis, the authors found a significant positive causal effect of the liability of gout on hypertension in both the IVW and PRS methods. Causality was estimated to be the same before and after involving confounding variables.&ldquo;The present study supported a causal effect of gout on hypertension, but multiple MR analyses have not provided conclusive evidence to support a direct causal effect of the urate level on hypertension,&rdquo; the authors said. &ldquo;Therefore, the causal effect of gout on hypertension may be mediated by the urate level, in combination with other urate-independent pathways.&rdquo;

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Analysis of Causal Relationship Between Gout and Hypertension

Nephrology Times

Gout has an incidence of 2.74 per 1,000 person-years and is linked to increased risks of mortality and comorbidities. It is an inflammatory disease caused by the accumulation ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe